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Abstract
Background: Hyperglycaemia is a common occurrence during cardiac surgery, however, there remains some
uncertainty surrounding the role of tight glycaemic control (blood glucose <180 mg/dL) during and/or after
surgery. The aim of this study was to systematically review the literature to determine the effects of tight versus
normal glycaemic control, during and after cardiac surgery, on measures of morbidity and mortality.
Method: The literature was systematically reviewed, based on pre-determined search criteria, for clinical trials
evaluating the effect of tight versus normal glycaemic control during and/or after cardiac surgery. Each paper was
reviewed by two, independent reviewers and data extracted for statistical analysis. Data from identified studies was
combined using meta-analysis (RevMan5
®). The results are presented either as odds ratios (OR) or mean differences
(MD) with 95% confidence intervals (CIs).
Results: A total of seven randomised controlled trials (RCTs) were identified in the literature, although not all trials
could be used in each analysis. Tight glycaemic control reduced the incidence of early mortality (death in ICU) (OR
0.52 [95% CI 0.30, 0.91]); of post-surgical atrial fibrillation (odds ratio (OR 0.76 [95%CI 0.58, 0.99]); the use of
epicardial pacing (OR 0.28 [95%CI 0.15, 0.54]); the duration of mechanical ventilation (mean difference (MD) -3.69
[95% CI -3.85, -3.54]) and length of stay in the intensive care unit (ICU) (MD -0.57 [95%CI -0.60, -0.55]) days.
Measures of the time spent on mechanical ventilation (I
2 94%) and time spent in ICU (I
2 99%) both had high
degrees of heterogeneity in the data.
Conclusion: The results from this study suggest that there may be some benefit to tight glycaemic control during
and after cardiac surgery. However, due to the limited number of studies available and the significant variability in
glucose levels; period of control; and the reporting of outcome measures, further research needs to be done to
provide a definitive answer on the benefits of tight glycaemic control for cardiac surgery patients.
Background
Hyperglycaemia (defined as a blood sugar > 180 mg/dL,
for the purpose of this review) during and after cardiac
surgery is a well-documented phenomenon [1,2] and is
part of the body’s stress response to surgery, resulting in
increased gluconeogenesis and glycogenolysis [3].
Uncontrolled hyperglycaemia can lead to: hypokalaemia,
hyponatraemia, arrhythmias and an increased risk of
ischemic brain injury [4]. In addition, it has been
demonstrated that hyperglycaemia may predispose
patients to an increased risk of post-surgical infections
through impaired phagocytic activity and decreased neu-
trophil function [5,6]. However, attempts to control
blood glucose levels by, intensive insulin treatment
(IIT), runs the risk of hypoglycaemia with serious cardi-
ovascular and neurological consequences.
Previously published evidence suggests that “tight” gly-
caemic control (defined as blood glucose maintained at
< 180 mg/dL) in critically ill, surgical and non-surgical
patients, improves morbidity and mortality [7], [8].
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ology recently issued guidelines [9] pertaining to the
control of hyperglycaemia in diabetic patients in an
Intensive Care Setting (ICU). However, the results of a
recently conducted, large, randomised controlled trial,
the NICE-SUGAR study, indicate that glycaemic control,
below 108 mg/dL may actually increase the rate of all-
cause mortality in ICU patients, both surgical and non-
surgical [10].
When it comes to the role of tight glycaemic control,
during and after cardiac surgery, there remains a certain
degree of uncertainty. The purpose of this study was to
conduct a systematic review of the literature on the
effects of “tight” versus “normal” glycaemic control, peri
and post-operatively, in patients undergoing cardiac sur-
gery in an attempt to help clarify the potential benefits
and risks associated with glucose control in this patient
population.
Methods
Search Strategy
A comprehensive search of published, peer reviewed
research was performed using Medline, the Cochrane
Library, Embase, Ovid, NHS Scotland E-Library, SIGN
(Scottish Intercollegiate Guidelines Network) and NICE
(National Institute of Clinical Excellence) to identify
relevant studies. The following exploded search terms:
‘tight’, ‘glucose’, ‘control’, ‘cardiac’, ‘surgery’, ‘CPB’,
‘CABG’, ‘heart,’‘ intensive’, ‘aggressive‘, ‘insulin‘, ‘therapy‘
and ‘strict’ were used. The reference lists of relevant
papers were then hand searched to identify any addi-
tional articles. Our search was limited to articles pub-
lished in the English language.
Study Selection Criteria
Each abstract returned using the above criteria was
independently reviewed twice. Those studies identified
as being RCTs were evaluated based on explicit inclu-
sion and exclusion criteria. Studies were included
which (1) reported data on cardiac-surgery patients;
(2) compared patients whose blood glucose was con-
trolled within a pre-determined, defined upper limit
(tight control) with those patients whose blood glucose
levels were either uncontrolled or maintained below a
higher limit (normal control); (3) that presented origi-
nal study data, or data that was extracted from a larger
systematic review, and (4) showed random allocation
of patients to the tight or normal blood glucose con-
trol groups. Studies were excluded which (1) involved
non-cardiac surgery patients, (2) only evaluated the
method of glucose control, rather than outcomes, (3)
had no extractable data (e.g. no means, standard devia-
tions or reference to the percentage of patients with an
adverse outcome).
Outcome measures
The outcome measures were chosen on the basis that at
least three independent sources reported extractable
data for patients with and without tight glycaemic con-
trol. The following outcome measures were reviewed:
(1)early mortality (within the first 30 days after surgery
or mortality in Coronary Care Unit (CCU)/ICU);
(2) atrial fibrillation (AF); (3) time in ICU; (4) time on
mechanical ventilation; (5) need for epicardial pacing.
Meta-Analysis
The meta-analysis was performed using RevMan5
® soft-
ware, from the Cochrane Collaboration. The incidences
of adverse events are presented as odds ratios (OR), and
results for continuous measures were presented as mean
differences (MD). A 95% confidence interval (CI) was
used, and the probability for overall effect was deemed
significant if p < 0.05. Heterogeneity values (I
2)a r ea l s o
reported for each of the outcome measures.
Results
Search Results
The results of the literature search identified 51 poten-
tially relevant reports on glucose control in cardiac sur-
gery (Figure 1). Based on the inclusion and exclusion
criteria, only nine of these studies met the criteria as
being randomised controlled trials. In these studies, the
definition of “tight” glycaemic control varied signifi-
cantly, with upper limits ranging from 100 mg/dL to
200 mg/dL. Conversely, “normal” control was defined as
either upper limit of 180 mg/dL to 250 mg/dL or no
active glycaemic control [11-18]. Of these, two studies
had to be excluded [5,11] as the only outcome measures
they reported were the effects of glycaemic control on
biochemical markers of inflammation, and thus were
not combinable with the other identified studies. Two of
the studies contained both diabetic and non-diabetic
patients, with random allocation to treatment groups
[13,15]. One study included only diabetic patients [18].
The remainder of the studies contained only non-
diabetic patients. Table 1 summarises the seven RCTs
included in the meta-analysis.
Meta-Analysis Results
Early Mortality
Three RCTs were identified that cited “early” mortality
as a primary outcome [15,16,18] (n = 1492). For the
purpose of our analysis, “early” mortality was defined as
mortality within the first 30 days [18], or mortality in
CCU/ICU [15,16]. Tight glycaemic control significantly
reduced early mortality following cardiac surgery (OR =
0.52, 95% CI 0.30 to -0.91, p < 0.02, Z = 2.29, heteroge-
neity I
2 = 71%, p < 0.06). Only two of the studies actu-
ally reported patient mortality events [16,15](Figure 2).
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Page 2 of 10Electronic database search – Medline, the Cochrane Library, 
Embase, Ovid, the NHS Scotland e-Library, SIGN, NICE and Google
51 potentially relevant 
abstracts identified
42 studies identified with extractable 
data for cardiac surgery patients
29 studies identified 
comparing tight vs 
normal glucose control
9 RCTs met inclusion 
criteria
6 RCTs included in 
meta-analysis
9 studies excluded: 
No extractable data for 
cardiac surgery patients
13 studies excluded:
No reference to tight vs
normal glucose control
20 studies excluded:
Non RCTs
No efforts to blind/
randomise
Unclear method
Target glucose levels for 
tight or control group not 
specified
No original data
3 studies excluded:
No comparable outcome 
measures
Figure 1 Flow chart of study identification, inclusion and exclusion criteria. This flow diagram illustrates the databases searched in this
review, the resulting number of potential studies identified by this search; and the number and reasons for excluding studies based our pre-
determined criteria. Following this process, seven RCTs were identified as meeting all criteria and were included in the meta-analysis. The two
studies that were excluded at the end of the process presented only data on inflammatory markers and cytokines rather than clinical outcomes
or endpoints.
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Page 3 of 10Table 1 Table of included RCTs
Subjects (n) Glucose
ranges
Early Mortality AF Pacing Time in ICU* Time on Ventilation
Author (year) Control
Period
Total (non-
DM/DM)
Tight/normal
control
mg/dL n(%) p n (%) p n (%) p Mean ± SD p Mean ± SD p
Control Tight Control Tight Control Tight Control Tight Control Tight Control Tight
Ingels [15]
(2006)
Post 970 (N/A) 477/493 < 220 < 110 37% 16% 0.005 N/A N/A – N/A N/A – N/A N/A – N/A N/A –
Chaney [12]
(1999)
Peri 20 (20/0) 10/10 - 100 -
150
N/A N/A – 2 (20%) 4
(40%)
N/A N/A N/A – N/A N/A – N/A N/A –
Gandhi [13]
(2007)
Peri 400 (327/73) 185/186 < 200 < 100 N/A N/A – 59
(32%)
54
(29%)
n.s. N/A N/A – N/A N/A – N/A N/A –
Hoedemaekers
[14] (2005)
Post 20 (20/0) 10/10 < 200 80 -
110
N/A N/A – N/A N/A – N/A N/A – 20.3 ±
2.5
22.1 ±
1.8
0.09 9.8 ±
4.6
11.2 ±
6.6
n.s.
Groban [16]
(2002)
Peri/Post 381 (381/0) 188/193 - 80 -
120
0% 1.60% n.s. 68
(35%)
60
(32%)
n.s. 2 (1%) 3
(2%)
n.s. N/A N/A – 32 ±
4.0
31 ±
4.0
N/A
Koskenkari
[17]
(2005)
Peri 40 (40/0) 20/20 < 180 108 -
180
N/A N/A – 14
(70%)
12
(60%)
N/A 12
(60%)
3
(15%)
0.008 48 ±
28.8
76.8 ±
112.8
0.8 12.9 ±
14.2
11.4 ±
20.1
0.1
Lazar [18]
(2004)
Peri 141 (N/A) 72/69 < 250 125 -
200
0% 0% n.s. 29
(42%)
12
16.6%
0.002 27
(39%)
10
13.8%
0.001 32.8
+2.6
17.3
+1.0
0.001 10.7 ±
0.6
6.9 ±
0.3
<
.001
This table describes the seven RCTs that met our inclusion/exclusion criteria and were included in the meta-analysis. In the table, “peri” and “post” designate the timing of glycaemic control as either during surgery
(peri) or after surgery (post). One study, Groban et al, maintained tight glycaemic control both during and after surgery. “DM” = diabetes mellitus (not specified if this was Type I or Type II). The glucose ranges for
the “tight” control and “normal” control groups are given. Where no glucose range is listed in the “normal” ranges indicates that no attempt was made to keep the patients under any glycaemic control. The number
of cases (n%) or the mean ± SD for each of the five outcome measures is listed for each study. Not every RCT included provided data on each of the outcome measures, thus some boxes are blank or listed as “N/A”
(not available). Where provided, the p-value for the statistical comparison within that study is also listed in the table.
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0The Lazar [18] study reported zero mortality in both
their tight and normal control groups, however, the
study comprised relatively small numbers (overall n =
141) when compared to the other two.
Atrial Fibrillation
The occurrence of atrial fibrillation (AF), post cardiac sur-
gery, was reported in five of the RCTs (total n = 488)
[12,13,16-18]. The results of the meta-analysis revealed a
significant reduction in AF in patients with tight glycaemic
control during surgery (OR = 0.76, 95% CI 0.58-0.99, p =
0.05, Z = 2.00, heterogeneity I
2 =5 5 % ,p=0 . 0 7 )( F i g u r e3 ) .
Length of Time in ICU/CCU
The duration of time spent in ICU/CCU following car-
diac surgery, for patients with and without tight glycae-
mic control, was reported in five of the RCTs
[13-15,17,18] (n = 201). However, two of these studies
presented their results in median number of days [14,13],
and three of them presented their data as mean hours or
days. We wrote to the authors of the two papers that pre-
sented their data as a median and range, and asked if they
could provide their data as means and standard
deviations, unfortunately, these data were not available.
Therefore, we conducted a meta-analysis of the three
papers that present their data as means and SDs
[ 1 4 , 1 7 , 1 8 ] .T h er e s u l t so ft h i sa n a l y s i sa r es h o w ni nF i g -
ure 4. There was a significant effect of tight glycaemic
control on reducing the time spent in ICU (OR = -0.57,
95% CI -0.60 to -0.55, p < 0.00001, Z = 43.54, heteroge-
neity I
2 = 99%, p < 0.00001). The results of this analysis
are heavily weighted by one study, Lazar et al [18], and
the mean values differ greatly between Lazar et al’s [18],
Hoedemaekers et al’s [14], and Kosenkari et al’s [17] stu-
dies, which is reflected in the heterogeneity analysis.
Length of Time on Mechanical Ventilation
T h e r ew e r ef i v eR C T st h a te x a m i n e dt h et i m es p e n to n
mechanical ventilation following cardiac surgery, with
and without tight glycaemic control [13,14,16-18]. One
study was excluded as they presented their data as the
number of patients who were delayed in being removed
from ventilation [13], rather than as the mean number
of hours on ventilation. The four studies that presented
their data as mean hours on ventilation were compared
Figure 3 Results of the meta-analysis on the incidence of atrial fibrillation following cardiac surgery, for patients with and without
tight glycaemic control. This figure illustrates the forest plot created as a result of the meta-analysis performed on the incidence of atrial
fibrillation (AF) following cardiac surgery for the tight and normal glycaemic control groups. As can be seen, tight glycaemic control
demonstrated a borderline significant reduction in the incidence of AF following cardiac surgery (p = 0.05). Only one study, Chaney et al
reported a higher incidence of AF in patients in the tight glycaemic control group, however their overall patient numbers was extremely small
(n = 20).
Figure 2 Results of the meta-analysis performed on the incidence of early mortality, following cardiac surgery, for patients with and
without tight glycaemic control. This figure illustrates the forest plot created as a result of the meta-analysis for early mortality data. “Early
mortality” was defined as death in CCU or within 30 days. Only three of the seven studies presented useable data and were included in the
analysis. Tight glycaemic control peri- and post-operatively significantly reduced early mortality as compared to normal glycaemic control
(p = 0.02).
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Page 5 of 10in a meta-analysis [14,16-18] (n = 582), and the results
are shown in Figure 5. Overall, there was a significant
reduction in the amount of time spent on ventilation for
those patients who had tight glycaemic control com-
pared to controls however, there was also significant
heterogeneity in the data which were heavily weighted
by the Lazar [18] study (OR = -3.69, 95% CI -3.85 to
-3.54, p < 0.000001, Z = 46.80, heterogeneity I
2 = 94%,
p < 0.00001).
The Need for Epicardial Pacing
The need for epicardial pacing following surgery was
recorded as an outcome measure in three of the RCTs
[16-18] (n = 562). Two of the three studies reported a
reduced need for pacing in patients with tight glycaemic
control. A meta-analysis performed on these, three stu-
dies, revealed a significant effect of tight glycaemic con-
trol on the need for epicardial pacing, with those in the
tight control group requiring less pacing (OR = 0.28,
95% CI 0.15-0.54, p = 0 < 0.001, Z = 3.83, heterogeneity
I
2 = 58%, p = 0.09) (Figure 6).
Discussion
To our knowledge, this is the first systematic review and
meta-analysis conducted solely on the effects of tight
and conventional glycaemic control in patients under-
going cardiac surgery. In our original literature serach,
we did identify three systematic reviews exploring the
effect of insulin infusion in critically ill patients (both
medical and surgical) [19-21]. However, in these
reviews, only one analysed the data for cardiac surgery
patients independently [21] and in these a targeted glu-
cose level was not part of the infusion protocol and thus
a comparison of “tight” versus “normal” control cannot
be made. However, in this review [21] there was no sig-
nificant effect of insulin (normally GIK - glucose, insul-
ing, potassium) infusion on mortality. The results from
this review indicate that tight glycaemic control, both
peri and post-operatively, may reduce mortality and
morbidity in cardiac surgery patients.
The effect of tight glycaemic control on mortality
following cardiac surgery
The results of our meta-analysis on early mortality,
including data for almost 1500 patients, from three
RCTs, suggest that there may be a significant reduction
in early mortality in the tight glycaemic control groups.
However, this data was heavily weighted by the Ingels
et al study [15], while the other two studies both had
Figure 5 Results of the meta-analysis conducted on the time spent on mechanical ventilation, following cardiac surgery, for patients
with and without tight glycaemic control. This figure illustrates the forest plot created from the meta-analysis of the time spent on
mechanical ventilation, following cardiac surgery, for patients with and without tight glycaemic control. The results of this analysis suggest that
patients who experienced tight glycaemic control peri and/or post-operatively spent significantly less time on mechanical ventilation (p <
0.00001). However, the results are heavily weighted by the Lazar (2004) study due to the wide ranges of time and large standard deviations in
the other four studies.
Figure 4 Results of the meta-analysis conducted on the time spent in CCU/ICU, for patients with and without tight glycaemic control,
following cardiac surgery. This figure illustrates the forest plot created from the meta-analysis of total time spent in CCU or ICU following
cardiac surgery, for those patients with and without tight glycaemic control. Although the results suggest that patients who were randomised to
the tight glycaemic control group spent significantly less time in CCU/ICU (p < 0.00001), the significant heterogeneity (99%) of this sample
makes it difficult to interpret these results. The data are significantly weighted by one study, the Lazar (2004) study, and the times spent in CCU/
ICU vary dramatically between groups.
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their data [16,18]. In a previous review by Gandhi et al
[19] they reported mortality data for 4355 patients,
receiving insulin infusions during and/or after surgery.
Although they found a significant reduction in overall
mortality with the use of insulin, they stated that the
cumulative evidence reported in their study is still insuf-
ficient, as a power calculation performed based on a
25% risk reduction with 90% power, taken at the 0.05,
two-sided significance level, would require over 11,000
patients in order to be adequately powered. It is clear
from this that our results, based on less than 1500
patients, are equally underpowered to answer this ques-
tion conclusively and further large-scale trials, with
appropriate double-blinding and definable outcome
measures are still needed.
Of interest, is the possible effect that the varying dura-
tion of glycaemic control may have had on data in this
review. In the Groban study [16], where there was very
little reported early mortality, tight glycaemic control
was maintained in both the peri- and post-operative
periods. Whereas the Ingels study [15], with the highest
rate of overall early mortality (in both treatment
groups), only reported controlling glucose levels post-
operatively. It is not possible to comment on the effect
which the differences in the timing of glycaemic control
may have had on the results. However, it does appear
that tight control extended beyond the peri-operative
period may reduce the incidence of early mortality. Pre-
vious reviews on the effect insulin infusion and patient
mortality have had similar mixes in the data, with infu-
sion times being variable between studies. In the future,
research is needed to clearly define the potential benefit
of glycaemic control peri operatively vs post-operatively
vs a combined method in order to tease out the effect
of timing on outcome.
Only one study, Ingels et al [15], looked at long-term
mortality as a consequence of tight or normal glycaemic
control, and found no significant differences between
the groups at two to four years following surgery. This
suggests that tight compared to normal glycaemic con-
trol may have a short-term effect on reducing mortality,
but this difference is not translated into a long-term
survival.
Our results on the effects of tight glycaemic control
on mortality are in contrast to those reported in the
NICE-SUGAR trial [10], which found that blood glucose
control below 108 mg/dL was associated with a signifi-
cant increase in all-cause mortality in ICU patients. The
reason for the discrepancy may be due to one or more
of the following reasons; 1) The NICE study only looked
at glucose control in the post-operative period. The stu-
dies in this review include data from both the peri-
operative and post-operative periods; 2) The NICE study
included data from surgical and non-surgical patients,
where this review includes data only from cardiac sur-
gery patients, who may have a different response to
tight glycaemic control compared to the general ICU
patient; and 3) the definition of “tight” glycaemic control
in the NICE study was 80-108 mg./dL, whereas in this
review, the glycaemic ranges used varied from < 110
mg/dL [15], 80-120 mg/dL [16] and 125-200 mg/dL
[18]. Interestingly, the only study that did not report
ANY mortality, the Lazar study, also had the highest
range of blood glucose levels in their tight control group
(125-200 mg/dL). This raises the question as to the opti-
mum level of glucose control, which has yet to be evalu-
ated in a randomised trial, and the possibility that lower
isn’t necessarily better.
Incidence of atrial fibrillation and the need for epicardial
pacing
Atrial fibrillation (AF) following cardiac surgery is com-
mon [22,23], affecting up to 20-30% of patients [23] and
may increase surgical morbidity and mortality [24]. In
our review, tight glycaemic control demonstrated a bor-
derline significant reduction in the incidence of AF fol-
lowing cardiac surgery (p = 0.05), although four of the
five RCTs reported fewer AF episodes in their tight con-
trol group when compared to their normal glucose
Figure 6 Results of the meta-analysis conducted on the need for epicardial pacing, following cardiac surgery, in patients with and
without tight glycaemic control. This figure illustrates the forest plot produced as a result of the meta-analysis on the need for epicardial
pacing in patients with and without tight glycaemic control. As can be seen in the figure, those patients with tight control experienced less
need for epicardial pacing (p = 0.0001).
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reduced need for epicardial pacing (p = 0.0001) in
patients with tight glycaemic control during cardiac sur-
gery. However, epicardial pacing is used not only to
control episodes of AF and other supra-ventricular
tachycardias, but also ventricular tachycardias and possi-
bly bradycardias, therefore the reduced need for pacing
cannot be interpreted solely as a reduced incidence of
AF.
The study by Groban et al [16] also examined the
need for cardioversion and/or medication to reverse AF
following a coronary artery bypass graft. Although fewer
of the patients with tight glycaemic control experienced
AF, more of them actually needed cardioversion for
these AF episodes, however this was not statistically sig-
nificant (p = 0.40). Also in this study, patients in the
treatment group received more anti-arrhythmic medica-
tions post-surgery, which could then affect the number
of AF episodes reported. Unfortunately, the study does
not detail if these anti-arrhythmic medications were
given as prophylaxis or whether they were given solely
in response to AF episodes. None of the other studies in
this meta-analysis gave any details on the need for cardi-
oversion or the use of anti-arrhythmic medications.
The pathological basis behind the increased incidence
of AF following cardiac surgery is unclear. Previous stu-
dies have suggested that AF may be due to the effects of
surgical trauma [25], inadequate cooling of the atrium
[26,27], withdrawal of pre-operative beta-blockers [28]
or possibly increased sympathetic activity [29]. Conse-
quently, there is a change or dispersion in the local
refractory periods in the atria, predisposing the tissue to
the development of fibrillation.
Due to the lack of understanding of the basic mechan-
isms of AF following cardiac surgery, it is difficult to pro-
pose a theory on the protective role of tight glycaemic
control. However, research has shown that insulin acts
on myocytes to increase their uptake of potassium [30],
which may then lead to a recovery of sinus rhythm fol-
lowing surgery. Zhang and colleagues have indicated that
insulin may act to stabilise the myocyte membrane
potential through the discovery of a new ion channel
which is sensitive to insulin [31]. In order to evaluate this
fully, it would be necessary to compare both patients’ gly-
caemic control during surgery and the amount of insulin
they received. Unfortunately, this data was not available
from the studies included in this review.
Time spent on mechanical ventilation and in CCU/ICU
following cardiac surgery
The results of this review on the length of time patients
spent on mechanical ventilation and overall time spent
in CCU or ICU are more difficult to interpret. In both
instances, the results are significant, but heavily
weighted by Lazar et al’s study [18]. The only conclu-
sions that can be drawn from this data is that tight gly-
caemic control may equate to better overall recovery,
however, there needs to be more research done in this
area, as well as some discussion of the mechanism by
which glycaemic control may exert these effects, as
t h e s ea r en o tc o n s i d e r e db yt h ea u t h o r sf r o mt h eo r i g i -
nal papers. Some of these mechanisms may include
(1) altering the immune response and reducing the risk
of infection [5,32,33]; (2) avoiding the pro-inflammatory
effect of hyperglycaemia which may contribute to post-
operative capillary leak syndrome, platelet dysfunction
and a higher risk of post-operative complications
[34,35]; (3) The insulin administration may protect the
heart in ischaemic conditions by increasing glucose
uptake by myocytes, increasing glycogenesis and redu-
cing the concentration of free fatty acids [36,37].
Limitations of this review
Although the results from this review raise the possibility
that tight glycaemic control may confer some benefit to
patients undergoing cardiac surgery, there are a number of
substantial limitations that must be considered when
interpreting or applying these results. Firstly, there were
few eligible RCTs with comparable outcomes that we
could include in this review. The trials which we did iden-
tify and were able to include used relatively small patient
populations as well as poorly defined outcome measures,
causing heterogeneity to be a persistent problem in our
meta-analysis. A number of outcomes included in our
results were secondary outcome measures and therefore
the original RCT study design may not have been opti-
mised for the evaluation of those outcomes.
In addition, there were important methodological dif-
ferences between studies: the proportion of diabetic and
non-diabetic patients; definitions of “tight” and “normal”
glycaemic control during and/or after surgery; and the
method of measuring the outcome measures. We were
unable to compare some data, despite contacting the
authors, because of different approaches to collecting
and reporting information, for example, the method of
measuring time spent in ICU.
Conclusion
The results of this systematic review of the literature and
meta-analysis indicate that tight compared to normal gly-
caemic control during and after cardiac surgery may
impart some benefit to patients following cardiac surgery,
including a reduction in early mortality and the inci-
dences of post-operative AF and the need for epicardial
pacing. There is some evidence that tight glycaemic con-
trol may also improve overall recovery by reducing the
time spent on mechanical ventilation and the time in
CCU/ICU. However, these results should be interpreted
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meta-analysis. Additional research is needed in order to
provide more definitive answers on the potential benefit
of tight glycaemic control during cardiac surgery. In
addition, future research should (1) address the differ-
ences between diabetic and non-diabetic patients with
respect to tight control and outcome; (2) the need to
have a clearly defined and accepted glycaemic range that
is considered “tight” control versus “normal” control;
(3) include larger, randomised, blinded studies; and
(4) examine longer term outcomes in addition to those
i m m e d i a t e l ya f t e rs u r g e r y .T h ei d e at h a ts o m eg l y c a e m i c
control is needed during major surgery such as coronary
artery bypass grafting, is currently well accepted, but
further research is now required to determine the precise
range to confer the most benefit, possibly by allocating
patients to groups with increasing levels of tight glycae-
mic control. The timing of this control and the benefits,
risks and underlying physiological mechanisms associated
with aggressive glycaemic control also require further
investigation.
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